Log in

NYSE:SYK - Stryker Stock Price, Forecast & News

$159.22
-4.11 (-2.52 %)
(As of 03/29/2020 04:00 PM ET)
Today's Range
$153.69
Now: $159.22
$164.12
50-Day Range
$126.50
MA: $188.80
$225.10
52-Week Range
$124.54
Now: $159.22
$226.30
Volume3.40 million shs
Average Volume3.69 million shs
Market Capitalization$59.64 billion
P/E Ratio29.05
Dividend Yield1.41%
Beta0.8
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products that include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. It also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems for use in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 80 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Read More
Stryker logo

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP86366710
Phone269-389-2600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$14.88 billion
Cash Flow$10.21 per share
Book Value$34.23 per share

Profitability

Net Income$2.08 billion

Miscellaneous

Employees40,000
Market Cap$59.64 billion
Next Earnings Date4/28/2020 (Estimated)
OptionableOptionable

Receive SYK News and Ratings via Email

Sign-up to receive the latest news and ratings for SYK and its competitors with MarketBeat's FREE daily newsletter.


Stryker (NYSE:SYK) Frequently Asked Questions

How has Stryker's stock been impacted by COVID-19 (Coronavirus)?

Stryker's stock was trading at $175.62 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SYK shares have decreased by 9.3% and is now trading at $159.22. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Stryker?

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 6 hold ratings and 16 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Stryker.

When is Stryker's next earnings date?

Stryker is scheduled to release its next quarterly earnings announcement on Tuesday, April 28th 2020. View our earnings forecast for Stryker.

How were Stryker's earnings last quarter?

Stryker Co. (NYSE:SYK) released its earnings results on Tuesday, January, 28th. The medical technology company reported $2.49 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $2.46 by $0.03. The medical technology company had revenue of $4.13 billion for the quarter, compared to analysts' expectations of $4.11 billion. Stryker had a net margin of 13.99% and a return on equity of 25.75%. The firm's revenue was up 8.8% on a year-over-year basis. During the same period in the previous year, the firm posted $2.18 EPS. View Stryker's earnings history.

How often does Stryker pay dividends? What is the dividend yield for Stryker?

Stryker declared a quarterly dividend on Friday, February 7th. Investors of record on Tuesday, March 31st will be given a dividend of $0.575 per share on Thursday, April 30th. This represents a $2.30 dividend on an annualized basis and a yield of 1.44%. The ex-dividend date is Monday, March 30th. View Stryker's dividend history.

What guidance has Stryker issued on next quarter's earnings?

Stryker issued an update on its FY20 earnings guidance on Tuesday, January, 28th. The company provided earnings per share guidance of $9.00-9.20 for the period, compared to the Thomson Reuters consensus estimate of $9.04.

What price target have analysts set for SYK?

22 brokerages have issued 1-year target prices for Stryker's stock. Their forecasts range from $145.00 to $248.00. On average, they anticipate Stryker's share price to reach $217.35 in the next twelve months. This suggests a possible upside of 36.5% from the stock's current price. View analysts' price targets for Stryker.

Has Stryker been receiving favorable news coverage?

News articles about SYK stock have been trending extremely negative recently, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Stryker earned a daily sentiment score of -4.0 on InfoTrie's scale. They also assigned media stories about the medical technology company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the next few days. View the latest news aboutStryker.

Are investors shorting Stryker?

Stryker saw a increase in short interest during the month of March. As of March 13th, there was short interest totaling 5,538,700 shares, an increase of 43.9% from the February 27th total of 3,850,000 shares. Based on an average daily trading volume, of 1,640,000 shares, the short-interest ratio is presently 3.4 days. Currently, 1.6% of the shares of the stock are sold short. View Stryker's Current Options Chain.

Who are some of Stryker's key competitors?

What other stocks do shareholders of Stryker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Walt Disney (DIS), Johnson & Johnson (JNJ), Medtronic (MDT), Visa (V), Home Depot (HD), AbbVie (ABBV), Boeing (BA), NVIDIA (NVDA), QUALCOMM (QCOM) and Abbott Laboratories (ABT).

Who are Stryker's key executives?

Stryker's management team includes the following people:
  • Mr. Kevin A. Lobo, Chairman & CEO (Age 54)
  • Mr. Timothy J. Scannell, Pres & COO (Age 54)
  • Mr. Glenn S. Boehnlein, VP & CFO (Age 57)
  • Mr. Michael D. Hutchinson, VP & Chief Legal Officer (Age 48)
  • Mr. Lonny J. Carpenter, Group Pres & Adviser to the CEO (Age 57)

What is Stryker's stock symbol?

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

Who are Stryker's major shareholders?

Stryker's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Greenleaf Trust (5.74%), State Street Corp (3.66%), FMR LLC (2.91%), Capital Research Global Investors (2.54%), Bank of New York Mellon Corp (1.86%) and Franklin Resources Inc. (1.52%). Company insiders that own Stryker stock include Allan C Golston, Bijoy Sagar, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Lonny J Carpenter, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Roch Doliveux, Srikant M Datar, Timothy J Scannell and Yin C Becker. View institutional ownership trends for Stryker.

Which major investors are selling Stryker stock?

SYK stock was sold by a variety of institutional investors in the last quarter, including Capital Research Global Investors, FMR LLC, Nuveen Asset Management LLC, Capital International Investors, Alliancebernstein L.P., Massachusetts Financial Services Co. MA, Janus Henderson Group PLC, and Jensen Investment Management Inc.. Company insiders that have sold Stryker company stock in the last year include Allan C Golston, Bijoy Sagar, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Louise Francesconi, M Kathryn Fink, Srikant M Datar, and Timothy J Scannell. View insider buying and selling activity for Stryker.

Which major investors are buying Stryker stock?

SYK stock was bought by a variety of institutional investors in the last quarter, including Norges Bank, Renaissance Technologies LLC, Point72 Asset Management L.P., CWS Financial Advisors LLC, PGGM Investments, State Street Corp, Geode Capital Management LLC, and Schroder Investment Management Group. View insider buying and selling activity for Stryker.

How do I buy shares of Stryker?

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Stryker's stock price today?

One share of SYK stock can currently be purchased for approximately $159.22.

How big of a company is Stryker?

Stryker has a market capitalization of $59.64 billion and generates $14.88 billion in revenue each year. The medical technology company earns $2.08 billion in net income (profit) each year or $8.26 on an earnings per share basis. Stryker employs 40,000 workers across the globe. View additional information about Stryker.

What is Stryker's official website?

The official website for Stryker is http://www.strykercorp.com/.

How can I contact Stryker?

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at 269-389-2600 or via email at [email protected]


MarketBeat Community Rating for Stryker (NYSE SYK)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  778 (Vote Outperform)
Underperform Votes:  754 (Vote Underperform)
Total Votes:  1,532
MarketBeat's community ratings are surveys of what our community members think about Stryker and other stocks. Vote "Outperform" if you believe SYK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SYK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/29/2020 by MarketBeat.com Staff

Featured Article: What are retained earnings?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel